Psilocybin For Grief and Loss

Losing someone we love can be a completely overwhelming experience. Our lives may become upended, we may be unable to function, we may even feel relief interwoven with the sadness.

And yet, all of this is a completely natural and universal response to loss. Even other animals, such as crows and elephants, grieve. Sorrow is not unique to humans.

Because grief is considered a natural part of life, like aging or death, there is no “cure” for it. However, in recent years, researchers have begun exploring whether psychedelic-assisted therapy, such as with psilocybin or ayahuasca, might offer a new way to interact with loss, especially for those who find the transition particularly difficult.

This article explores how psilocybin may specifically help the bereaved deepen their emotional processing and reconnect with what makes life feel meaningful. While research on psilocybin for grief is still in the early stages, adjacent studies centered on issues like depression and end-of-life anxiety or existential distress offer a valuable foundation for exploration.

Understanding Grief and Loss

Grief is a natural response to losing someone or something meaningful. It can follow the death of a loved one, but also the loss of a pet, the end of a relationship, a major life transition, or even a shift in identity or health. While our culture, religion, or personal values might inform how we mourn, it is still a deeply individual experience. There is no single “right” way to grieve.

The Emotional And Psychological Effects Of Grief

Rather than being a single emotion, grief acts as a "container" for a wide range of feelings and experiences. So, although it is often defined as an emotional response to loss, grief affects nearly every aspect of life:

• Emotional: sadness, anger, guilt, relief, numbness
• Cognitive: difficulty concentrating, intrusive memories, lack of motivation
• Physical: fatigue, sleep disruption, changes in appetite and immune function
• Existential: questioning meaning, purpose, or belief systems

A person may be unable to sleep yet struggle to get out of bed. They may feel relief one moment and profound sorrow the next. While these experiences are normal, the process can often unfold slowly and unpredictably, making grief one of the more challenging experiences of people’s lives.

Why Processing Loss Can Be Challenging

One of the challenges of grief is that it resists resolution. Supportive relationships, therapy, community, and rituals can all help create space for the process to unfold organically, but there are no clear stages, no universal timeline, and no definitive endpoint to bereavement.

As many experts note, grief is not a problem to solve; it is an experience to move through, however long it may take. This can be especially difficult in cultures that prioritize productivity, emotional restraint, or “moving on” quickly. In some cases, pressure to suppress or overcome your grief may actually deepen feelings of isolation.

Acute Grief Vs Prolonged Grief: What’s The Difference?

In the early stages of loss, many people experience what clinicians refer to as “acute grief.” This period may involve intense sadness, preoccupation with the loss, emotional volatility, or withdrawal from everyday life.

For most people, this intensity softens over time, even if the grief itself never fully disappears. But for others, these intense feelings can remain debilitating for years. Some experience chronic depression, anxiety, or emotional numbness. Others may become stuck in repetitive cycles of rumination and avoidance that interfere with daily functioning. This is sometimes described as prolonged grief or complicated grief.

It’s within this more complex terrain that researchers are beginning to ask whether psilocybin-assisted therapy might offer support.

What the Research Says About Psilocybin and Emotional Healing

While direct research on psilocybin for grief remains limited - with basic online searches primarily yielding anecdotal accounts - studies on treatment-resistant depression, existential suffering, and end-of-life anxiety show overlaps with grief-related distress. The therapeutic benefits observed in these related conditions could indicate how psilocybin treatment might similarly support those navigating the grieving process.

Studies Involving Existential Distress or End-of-life Anxiety

Two widely cited clinical trials published in 2016 provide insight into psilocybin’s potential use for grief. These studies found that psilocybin-assisted therapy, combined with psychological support, significantly reduced anxiety and depression in patients with life-threatening cancer.

• Griffiths, et al., 2016 reported that a single high-dose psilocybin session produced substantial and sustained reductions in depression and anxiety in 80% of participants.
• Ross, et al., 2016 similarly reported rapid and lasting improvements in emotional well-being for participants with existential distress.

Importantly, participants described changes in their relationship to their mortality. Many said their experiences centered around forgiveness, connection, love, or acceptance of death. Although these studies did not focus specifically on grief, they suggest that psilocybin may help individuals navigate emotionally and existentially difficult experiences.

Research on Psilocybin and Depression

Other research by Robin Carhart-Harris and colleagues showed that two doses of psilocybin could rapidly and significantly reduce symptoms of treatment-resistant depression. Subsequent studies by Carhart-Harris suggest that psilocybin can temporarily disrupt rigid patterns of thinking, which may be relevant for people experiencing prolonged grief, where emotional states and thought patterns can become stuck or repetitive.

End-of-life anxiety, depression, and grief are distinct experiences, but they overlap in meaningful ways that researchers are just beginning to explore. One recent survey found that psychedelic users self-reported improvements in grief symptoms and emotional acceptance after psychedelic experiences. While surveys have limitations, this preliminary study illustrates how psilocybin research could benefit grief work.

How Psilocybin May Support Emotional Processing

While researchers are still studying the biological mechanisms behind psilocybin, current evidence suggests it can help individuals reframe entrenched emotional patterns by increasing brain connectivity and reducing activity in networks associated with rigid, self-referential thought.

This temporary disruption to the brain’s default patterns of activity may create an opportunity for emotional processing and perspective shifts. Psilocybin has been shown to affect:

• Emotional Openness
  Psilocybin may reduce experiential avoidance, making it easier to feel emotions that have been suppressed or difficult to access. For someone grieving, this could mean fully experiencing sadness, anger, longing, or regret rather than remaining emotionally numb.
• Shifts in Perspective
  Many participants in psilocybin studies describe being able to see their circumstances differently. This might involve softening self-blame, reconsidering painful narratives, or approaching loss with greater acceptance.
• Meaning-Making
  Grief can profoundly disrupt a person’s sense of meaning and identity. Psychedelic experiences may support the reconstruction of personal narratives, helping individuals find new ways to understand their loss and place in the world.
• A Sense of Connection
  Psilocybin study participants often report feelings of connection to loved ones, nature, or something larger than themselves. For some bereaved individuals, this can shift the experience of loss from one of total absence to one that includes ongoing connection in a different form.

At the same time, these experiences are highly variable. Psilocybin does not guarantee healing or relief, and difficult emotional experiences can emerge during sessions. Context, preparation, support, and professional medical guidance matter in these experiences.

The Role of Therapy and Integration

Grief itself can feel psychologically disorienting and life-altering, much like a psychedelic experience. Both require integration, the gradual process of making meaning from emotionally significant experiences and incorporating them into daily life.

This is why psilocybin therapy includes much more than the psychedelic session itself, and why there are support systems in place for grief.

The Importance Of Guided Support When Working Through Grief

Studies have found that many people feel dissatisfied with the support they receive after bereavement, which can intensify the emotional and psychological strain of grief. But guided support can help reduce isolation, normalize the non-linear and intense nature of grief, buffer against the stress of loss, and help people navigate overwhelm in daily life.

In the context of psilocybin therapy, programs that include preparation before the psychedelic experience and integration after would be especially important for the bereaved. This structure offers emotional and medical support, experienced facilitators and therapists, and a safe and comfortable environment to process loss and intense emotions during and after the psychedelic session.

Translating Insights Into Daily Life

Integration can be especially important for grief work because, like a psychedelic experience, grief needs to be processed and woven into daily life for lasting healing to occur. Guided support helps a person make meaning from both the loss and the psychedelic session. Without this process, a person may continue to feel emotionally stuck or overwhelmed by grief.

Practices such as therapy, journaling, mindfulness, somatic work, and community support can help ground the loss within a person’s life story and prevent the long-term health risks associated with grief.

What Researchers Are Still Exploring

Psilocybin therapy is not appropriate for everyone. Careful screening, professional guidance, and ethical therapeutic support are essential. It’s also important to emphasize that the clinical information available on psilocybin for grief is minimal. And despite growing public interest, psilocybin therapy itself remains an emerging field with research limitations and open questions.

Limitations Of Current Research

Most existing psilocybin studies:

• Involve relatively small sample sizes, in highly controlled settings
• Focus primarily on depression, anxiety, and end-of-life distress rather than grief itself
• Have limited long-term follow-up data
• Potential bias due to the difficulty of blinding participants in clinical trials
• Rely on subjective experiences that are difficult to measure scientifically

The psychedelic experience is also highly individual, making outcomes difficult to predict.

Ongoing Research and Ethical Considerations

Researchers at institutions including Johns Hopkins University, New York University, and Imperial College London are continuing to study psilocybin across a range of mental health conditions. Some early investigations are beginning to look more specifically at grief and bereavement, including prolonged grief disorder.

At the same time, ethical concerns remain important. Bereaved individuals are emotionally vulnerable and may be at greater risk of harm from poorly structured psychedelic experiences or unethical practitioners. Researcher Mary-Frances O'Connor has also cautioned that psychedelic therapy may not be appropriate for everyone experiencing grief, particularly if the individual is already moving through the grieving process in a healthy and supported way.

Psilocybin also remains illegal in many parts of the world, though regulations are gradually changing as research expands.

Final Thoughts

“Grief and love are sisters, woven together from the beginning,” writes grief therapist Francis Weller. “There is no love that does not contain loss and no loss that is not a reminder of the love we carry for what we once held close.”

Grief asks us to carry both love and loss at the same time. While many people navigate this process through time and with tools like therapy, others may need more support. Psilocybin-assisted therapy does not promise to erase grief, nor can it, but it may provide some individuals with a new way to process their loss. As research evolves, its potential role in shifting one's relationship with grief remains an important topic of discussion.

Frequently Asked Questions

Sources

1. Szuhany, Kristin L., et al. "Prolonged grief disorder: Course, diagnosis, assessment, and treatment." Focus 19.2 (2021): 161-172.
2. Griffiths, Roland R., et al. “Psilocybin Produces Substantial and Sustained Decreases in Depression and Anxiety in Patients with Life-Threatening Cancer.” Journal of Psychopharmacology, vol. 30, no. 12, 2016, pp. 1181–1197.
3. Ross, Stephen, et al. “Rapid and Sustained Symptom Reduction Following Psilocybin Treatment for Anxiety and Depression in Patients with Life-Threatening Cancer.” Journal of Psychopharmacology, vol. 30, no. 12, 2016, pp. 1165–1180.
4. Carhart-Harris, Robin L., et al. "Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study." The Lancet Psychiatry 3.7 (2016): 619-627.
5. Carhart-Harris, R L, and K J Friston. “REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.” Pharmacological reviews vol. 71,3 (2019): 316-344. doi:10.1124/pr.118.017160
6. Low, Fiona, and Mitch Earleywine. “Psychedelic Experiences after Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences.” Journal of Psychoactive Drugs, 21 June 2023, pp. 1–8, pubmed.ncbi.nlm.nih.gov/37343940/, https://doi.org/10.1080/02791072.2023.2228303.
7. ‌Cacciatore, Joanne et al. “What is good grief support? Exploring the actors and actions in social support after traumatic grief.” PloS one vol. 16,5 e0252324. 27 May. 2021, doi:10.1371/journal.pone.0252324
8. Hilberdink, Charlotte E et al. “Bereavement issues and prolonged grief disorder: A global perspective.” Global mental health (Cambridge, England) vol. 10 e32. 20 Jun. 2023, doi:10.1017/gmh.2023.28